Comparison of the abilities of the plasma triglyceride/high-density lipoprotein cholesterol ratio and the metabolic syndrome to identify insulin resistance

Diabetes and Vascular Disease Research

Volumn 10, Issue 4, 2013, Pages 346-352

  Salazar, Martin R ^a   Carbajal, Horacio A ^a   Espeche, Walter G ^a   Leiva Sisnieguez, Carlos E ^a   March, Carlos E ^a   Balbín, Eduardo ^a   Dulbecco, Carlos A ^a   Aizpurúa, Marcelo ^b   Marillet, Alberto G ^c   Reaven, Gerald M ^d  

^a Immunogenetics Service   (Argentina)

^b Hospital Municipal de Rauch   (Argentina)

^c Hospital Municipal de San Andrés de Giles   (Argentina)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardio metabolic risk; insulin resistance; metabolic syndrome; triglyceride high density lipoprotein cholesterol ratio

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

CARDIO-METABOLIC RISK; INSULIN RESISTANCE; METABOLIC SYNDROME; TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84879346318     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113479809     Document Type: Article

References (27)

1. Yeni-Komshian H, Carantoni M, Abbasi F, et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care. 2000 ; 23: 171-175
2. Zavaroni I, Bonini L, Gasparini P, et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism. 1999 ; 48: 989-994
3. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998 ; 83: 2773-2776
4. Facchini FS, Hua N, Abbasi F, et al. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001 ; 86: 3574-3578
5. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Circulation. 2009 ; 120: 1640-1645
6. McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003 ; 139: 802-809
7. McLaughlin T, Reaven G, Abbasi F, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol. 2005 ; 96: 399-404
8. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med. 1992 ; 231: 25-30
9. Li C, Ford ES, Meng YX, et al. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?. Cardiovasc Diabetol. 2008 ; 7: 4
10. Salazar MR, Carbajal HA, Espeche WG, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012 ; 109: 1749-1753
11. Salazar MR, Carbajal HA, Curciarello JO, et al. Alanine-aminotransferase: an early marker for insulin resistance?. Medicina (B Aires). 2007 ; 67: 125-130
12. Salazar MR, Carbajal HA, Marillet AG, et al. Glomerular filtration rate, cardiovascular risk factors and insulin resistance. Medicina (B Aires). 2009 ; 69: 541-546
13. Sumner AE, Harman JL, Buxbaum SG, et al. The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart Study. Metab Syndr Relat Disord. 2010 ; 8: 511-514
14. Salazar MR, Carbajal HA, Espeche WG, et al. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diab Vasc Dis Res. 2011 ; 8: 109-116
15. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996 ; 334: 952-957
16. Reaven GM. Insulin resistance: from bit player to centre stage. CMAJ. 2011 ; 183: 536-537
17. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005 ; 28: 1769-1778
18. Wilson PW, D'Agostino RB, Parise H, et al. Metabolic syndrome as a predictor of cardiovascular disease and type 2 diabetes. Circulation. 2005 ; 112: 3066-3072
19. Liao Y, Kwon S, Shaughnessy S, et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004 ; 27: 978-983
20. Sierra-Johnson J, Johnson BD, Allison TG, et al. Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance. Diabetes Care. 2006 ; 29: 668-672
21. Musso G, Gambino R, Bo S, et al. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care. 2008 ; 31: 562-568
22. Festa A, D'Agostino R, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000 ; 102: 42-47
23. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?. Circulation. 2004 ; 109: 2818-2825
24. De León AC, Coello SD, González DA, et al. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands. Diabet Med. 2012 ; 29: 399-403
25. Hadaegh F, Khalili D, Ghasemi A, et al. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis. 2009 ; 19: 401-408
26. Bittner V, Johnson BD, Zineh I, et al. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am Heart J. 2009 ; 157: 548-555
27. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011 ; 377: 1085-1095